These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2659391)

  • 1. HLA-D/DR identity results in a positive CML reaction.
    Buc M; Porubská S; Bencová M; Nyulassy S; Stefanovic J
    Folia Biol (Praha); 1989; 35(2):78-89. PubMed ID: 2659391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DP antigens provide the proliferative impetus for the generation of cytotoxic T lymphocytes.
    Buc M; Porubská S; Bencova M; Nyulassy S; Stefanovic J
    Tissue Antigens; 1988 Nov; 32(5):291-4. PubMed ID: 3265548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HLA-DQ antigens in the induction of cytotoxic T lymphocytes.
    Porubská S; Buc M; Bencová M; Sausová E
    Folia Biol (Praha); 1993; 39(5):256-61. PubMed ID: 8206171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HLA class II antigens in the induction of cytotoxic T lymphocytes.
    Demesová V; Buc M; Ferencík S; Sasazuki T; Shawkatová I; Porubská S
    Eur J Immunogenet; 1995 Dec; 22(6):425-34. PubMed ID: 8597559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human cytotoxic T cell clones that recognize HLA-DQw3 antigens].
    Fukasawa Y
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):682-9. PubMed ID: 3023217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of HLA-D/DR antigen disparity in CTL generation in vitro.
    Johnsen HE; Madsen M; Mossin J; Kristensen T
    Tissue Antigens; 1983 Aug; 22(2):142-50. PubMed ID: 6604961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Products of HLA class I and class II (B,C,DP,DQ,DR) genes all contribute to induction of recipient anti-donor responses in rejected kidneys.
    Bonneville M; Moreau JF; Blokland E; Pool J; Charron D; Goulmy E; Soulillou JP
    Transplant Proc; 1988 Apr; 20(2):193-5. PubMed ID: 3284038
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of a novel HLA-DQ specificity. II. Cellular analysis by cytotoxic T-cell clones.
    Kojima H; Fukasawa Y; Ishikawa N; Tajima Y; Wakisaka A; Aizawa M
    Immunogenetics; 1988; 27(2):145-7. PubMed ID: 3257198
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of HLA in intragraft cellular immunity in human liver transplantation.
    Duquesnoy RJ; Saidman S; Markus BH; Demetris AJ; Zeevi A
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):724-7. PubMed ID: 3279662
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA regulates postrenal transplant CML nonreactivity.
    Goulmy E; Blokland E; Persijn G; Paul LC; Wilmink J; van Rood JJ
    J Immunol; 1985 Nov; 135(5):3082-6. PubMed ID: 3900203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins.
    Burakoff SJ; Clayberger C; Hemler M; Krensky AM; Reiss CS; Robbins E; Sanchez-Madrid F; Springer TA; Strominger JL; Ware CF
    Diagn Immunol; 1983; 1(3):116-9. PubMed ID: 6238749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual differences in the cytotoxic T-lymphocyte response in man to public HLA determinants.
    Breur-Vriesendorp BS; Ivanyi P
    Cell Immunol; 1986 Dec; 103(2):252-71. PubMed ID: 3492287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of HLA antigen disparity on CML reactivity.
    Dohi K; Ono E; Fukuda Y; Asahara T; Yahata H; Ezaki H
    Hiroshima J Med Sci; 1984 Sep; 33(3):503-6. PubMed ID: 6334675
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of self HLA-DR-specific CD3+CD4-CD8+ cytotoxic T cells in chronic graft-versus-host disease.
    Yamamoto M; Sugihara K; Ohtsuki F; Tsujino Y; Tanaka A; Kamiya T; Wada H; Kanamaru A; Hara H; Yano A
    Bone Marrow Transplant; 1994 Oct; 14(4):525-33. PubMed ID: 7858527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
    Dowding CR; Gordon MY; Goldman JM
    Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
    Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.